Microarray technology and its effect on breast cancer (re)classification and prediction of outcome

Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.

Frontiers in nutrition·2026

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.

Maturitas·2026

Podcast: Patient voices and clinical advances-Elinzanetant for menopause symptom management associated with breast cancer treatment in the OASIS-4 trial.

Women's health (London, England)·2026

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Women's health (London, England)·2026

Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study.

Journal of the National Cancer Institute·2026

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors.

Advances in radiation oncology·2026

Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).

Breast cancer research : BCR·2026

Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.

Breast cancer research : BCR·2026

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Breast cancer research : BCR·2026

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

Breast cancer research : BCR·2026

The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.

Breast cancer research : BCR·2026

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Breast cancer research : BCR·2026

Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

Journal of the National Cancer Institute·2026

Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.

Journal of the National Cancer Institute·2026

Mayo Clinic classification of presacral tumors: evolution of classifications and systematic review of pathologies.

BJS open·2026

Survival outcomes of expansile versus infiltrative subtype in primary mucinous ovarian carcinomas: A retrospective study in Thailand.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Long-term prospective assessment of quality of life and physical function in malignant lymphoma patients undergoing chemotherapy.

Medicine·2026

Risk factors for local recurrence and metastasis of eyelid sebaceous carcinoma after complete excision: A large cohort study in Japan.

Indian journal of ophthalmology·2026

Related Experiment Videos

Microarray technology and its effect on breast cancer (re)classification and prediction of outcome

Related Concept Videos

Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.

Podcast: Patient voices and clinical advances-Elinzanetant for menopause symptom management associated with breast cancer treatment in the OASIS-4 trial.

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study.

18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Guided Stereotactic Body Radiation Therapy in Advanced Breast Cancer Patients Treated WithCyclin-Dependent Kinase 4/6 Inhibitors.

Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).

Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.

Mayo Clinic classification of presacral tumors: evolution of classifications and systematic review of pathologies.

Survival outcomes of expansile versus infiltrative subtype in primary mucinous ovarian carcinomas: A retrospective study in Thailand.

Long-term prospective assessment of quality of life and physical function in malignant lymphoma patients undergoing chemotherapy.

Risk factors for local recurrence and metastasis of eyelid sebaceous carcinoma after complete excision: A large cohort study in Japan.

Related Experiment Videos

Microarray technology and its effect on breast cancer (re)classification and prediction of outcome

Related Concept Videos

Related Articles